← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Menogenix, Inc.
Aurora, CO
$1,188,027
Total funding
2
Grants
Funding over time
peak $693.4K · FY2018–20$1M$750K$500K$250K$0
'18
'19
'20
Funding mix
By agency
NIH$1,188,027 · 2
By mechanism
R43$1,188,027 · 2
Investigators at Menogenix, Inc.
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
All-Time
Most funded here, all years
Largest grants
Effect of Repeated Administration of G-CSF on Hot Flashes and Other Vasomotor Symptoms of Menopause$693,360
R43 · FY2018 · AG
Expanded Clinical Trial of Granulocyte Colony-Stimulating Factor (G-CSF) to Treat Hot Flush and Other Vasomotor Symptoms in Women with Naturally-Occurring and Surgically-Induced Menopause$299,831
R43 · FY2020 · AG
Effect of Repeated Administration of G-CSF on Hot Flashes and Other Vasomotor Symptoms of Menopause$194,836
R43 · FY2019 · AG